Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

234 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Association Analysis of TP53 rs1042522, MDM2 rs2279744, rs3730485, MDM4 rs4245739 Variants and Acute Myeloid Leukemia Susceptibility, Risk Stratification Scores, and Clinical Features: An Exploratory Study.
Tripon F, Iancu M, Trifa A, Crauciuc GA, Boglis A, Balla B, Cosma A, Dima D, Candea M, Lazar E, Jimbu L, Banescu C. Tripon F, et al. Among authors: dima d. J Clin Med. 2020 Jun 1;9(6):1672. doi: 10.3390/jcm9061672. J Clin Med. 2020. PMID: 32492903 Free PMC article.
CALR versus JAK2 mutated essential thrombocythaemia - a report on 141 patients.
Trifa AP, Popp RA, Cucuianu A, Bănescu C, Tevet M, Martin B, Murat M, Vesa SC, Dima D, Cândea M, Militaru MS, Pop IV. Trifa AP, et al. Among authors: dima d. Br J Haematol. 2015 Jan;168(1):151-3. doi: 10.1111/bjh.13076. Epub 2014 Aug 8. Br J Haematol. 2015. PMID: 25103987 Free article. No abstract available.
TERT rs2736100 A>C SNP and JAK2 46/1 haplotype significantly contribute to the occurrence of JAK2 V617F and CALR mutated myeloproliferative neoplasms - a multicentric study on 529 patients.
Trifa AP, Bănescu C, Tevet M, Bojan A, Dima D, Urian L, Török-Vistai T, Popov VM, Zdrenghea M, Petrov L, Vasilache A, Murat M, Georgescu D, Popescu M, Pătrinoiu O, Balea M, Costache R, Coleș E, Șaguna C, Berbec N, Vlădăreanu AM, Mihăilă RG, Bumbea H, Cucuianu A, Popp RA. Trifa AP, et al. Among authors: dima d. Br J Haematol. 2016 Jul;174(2):218-26. doi: 10.1111/bjh.14041. Epub 2016 Apr 7. Br J Haematol. 2016. PMID: 27061303 Free article.
Among a panel of polymorphisms in genes related to oxidative stress, CAT-262 C>T, GPX1 Pro198Leu and GSTP1 Ile105Val influence the risk of developing BCR-ABL negative myeloproliferative neoplasms.
Trifa AP, Bănescu C, Dima D, Bojan AS, Tevet M, Moldovan VG, Vesa ȘC, Murat M, Pop IV, Skrypnyk C, Popp RA. Trifa AP, et al. Among authors: dima d. Hematology. 2016 Oct;21(9):520-5. doi: 10.1080/10245332.2016.1163889. Epub 2016 Mar 30. Hematology. 2016. PMID: 27077777
Fibroblast dynamics as an in vitro screening platform for anti-fibrotic drugs in primary myelofibrosis.
Tomuleasa C, Selicean S, Gafencu G, Petrushev B, Pop L, Berce C, Jurj A, Trifa A, Rosu AM, Pasca S, Magdo L, Zdrenghea M, Dima D, Tanase A, Frinc I, Bojan A, Berindan-Neagoe I, Ghiaur G, Ciurea SO. Tomuleasa C, et al. Among authors: dima d. J Cell Physiol. 2018 Jan;233(1):422-433. doi: 10.1002/jcp.25902. Epub 2017 May 23. J Cell Physiol. 2018. PMID: 28294327
234 results